Pieris Pharmaceuticals Inc buy BiotechBee
Start price
02.01.23
/
60%
€1.04
Target price
31.12.25
€3.00
Performance (%)
-26.41%
End price
05.05.23
€0.77
Summary
This prediction ended on 05.05.23 with a price of €0.77. The prediction for Pieris Pharmaceuticals Inc disappointed with a performance of -26.41%. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Pieris Pharmaceuticals Inc | - | - | - | - |
| iShares Core DAX® | 1,72 % | 3,37 % | 5,89 % | 52,38 % |
| iShares Nasdaq 100 | -4,56 % | -4,24 % | 21,39 % | 72,45 % |
| iShares Nikkei 225® | -7,12 % | -11,87 % | 42,36 % | 57,58 % |
| iShares S&P 500 | -0,89 % | 1,69 % | 19,49 % | 62,15 % |
According to BiotechBee what are the pros and cons of Pieris Pharmaceuticals Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year